Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder, typically
characterized by anovulation, infertility, obesity, insulin resistance, and polycystic ovaries …

Background Metformin is the gold standard insulin sensitizer, which is widely used to treat
insulin resistance in polycystic ovary syndrome (PCOS). However, metformin may induce …

Background A couple may be considered to have fertility problems if they have been trying
to conceive for over a year with no success. This may affect up to a quarter of all couples …

Polycystic ovary syndrome (PCOS) is a common endocrine disorder, with complex etiology
and pathophysiology, which remains poorly understood. It affects about 5–10% of women of …

Polycystic ovary syndrome is a common cause of anovulation and infertility, and a risk factor
for development of metabolic syndrome and endometrial cancer. Systematic review and …

Cell signaling via inositol phosphates, in particular via the second messenger myo‐inositol
1, 4, 5‐trisphosphate, and phosphoinositides comprises a huge field of biology. Of the nine …

Aim: In this study, we aim to verify whether the two molecules have a synergistic action by
acting on their specific cellular pathways. The effectiveness in reducing the risk of metabolic …

To investigate the effects of treatment with Myo-inositol (an insulin sensitizing drug), on
circulating insulin, glucose tolerance, ovulation and serum androgens concentrations in …

Objective. To evaluate the effects the administration of myo-inositol (MYO) on hormonal
parameters in a group of PCOS patients. Design. Controlled clinical study. Setting. PCOS …

Objective: To evaluate the effects the administration of myo-inositol (MYO) on hormonal
parameters in a group of polycystic ovary syndrome (PCOS) patients. Design: Controlled …